Cargando…
C-Terminal Truncated HBx Facilitates Oncogenesis by Modulating Cell Cycle and Glucose Metabolism in FXR-Deficient Hepatocellular Carcinoma
Farnesoid X receptor (FXR) is a nuclear receptor known to play protective roles in anti-hepatocarcinogenesis and regulation of the basal metabolism of glucose, lipids, and bile acids. FXR expression is low or absent in HBV-associated hepatocarcinogenesis. Full-length HBx and HBx C-terminal truncatio...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10048952/ https://www.ncbi.nlm.nih.gov/pubmed/36982249 http://dx.doi.org/10.3390/ijms24065174 |
_version_ | 1785014326523854848 |
---|---|
author | Wu, Xuejun Ni, Zhengzhong Song, Tiantian Lv, Wenya Chen, Yan Huang, Danmei Xie, Yangmin Huang, Weiyi Niu, Yongdong |
author_facet | Wu, Xuejun Ni, Zhengzhong Song, Tiantian Lv, Wenya Chen, Yan Huang, Danmei Xie, Yangmin Huang, Weiyi Niu, Yongdong |
author_sort | Wu, Xuejun |
collection | PubMed |
description | Farnesoid X receptor (FXR) is a nuclear receptor known to play protective roles in anti-hepatocarcinogenesis and regulation of the basal metabolism of glucose, lipids, and bile acids. FXR expression is low or absent in HBV-associated hepatocarcinogenesis. Full-length HBx and HBx C-terminal truncation are frequently found in clinical HCC samples and play distinct roles in hepatocarcinogenesis by interacting with FXR or FXR signaling. However, the impact of C-terminal truncated HBx on the progression of hepatocarcinogenesis in the absence of FXR is unclear. In this study, we found that one known FXR binding protein, a C-terminal truncated X protein (HBx C40) enhanced obviously and promoted tumor cell proliferation and migration by altering cell cycle distribution and inducing apoptosis in the absence of FXR. HBx C40 enhanced the growth of FXR-deficient tumors in vivo. In addition, RNA-sequencing analysis showed that HBx C40 overexpression could affect energy metabolism. Overexpressed HSPB8 aggravated the metabolic reprogramming induced by down-regulating glucose metabolism-associated hexokinase 2 genes in HBx C40-induced hepatocarcinogenesis. Overall, our study suggests that C-terminal truncated HBx C40 synergizes with FXR deficiency by altering cell cycle distribution as well as disturbing glucose metabolism to promote HCC development. |
format | Online Article Text |
id | pubmed-10048952 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100489522023-03-29 C-Terminal Truncated HBx Facilitates Oncogenesis by Modulating Cell Cycle and Glucose Metabolism in FXR-Deficient Hepatocellular Carcinoma Wu, Xuejun Ni, Zhengzhong Song, Tiantian Lv, Wenya Chen, Yan Huang, Danmei Xie, Yangmin Huang, Weiyi Niu, Yongdong Int J Mol Sci Article Farnesoid X receptor (FXR) is a nuclear receptor known to play protective roles in anti-hepatocarcinogenesis and regulation of the basal metabolism of glucose, lipids, and bile acids. FXR expression is low or absent in HBV-associated hepatocarcinogenesis. Full-length HBx and HBx C-terminal truncation are frequently found in clinical HCC samples and play distinct roles in hepatocarcinogenesis by interacting with FXR or FXR signaling. However, the impact of C-terminal truncated HBx on the progression of hepatocarcinogenesis in the absence of FXR is unclear. In this study, we found that one known FXR binding protein, a C-terminal truncated X protein (HBx C40) enhanced obviously and promoted tumor cell proliferation and migration by altering cell cycle distribution and inducing apoptosis in the absence of FXR. HBx C40 enhanced the growth of FXR-deficient tumors in vivo. In addition, RNA-sequencing analysis showed that HBx C40 overexpression could affect energy metabolism. Overexpressed HSPB8 aggravated the metabolic reprogramming induced by down-regulating glucose metabolism-associated hexokinase 2 genes in HBx C40-induced hepatocarcinogenesis. Overall, our study suggests that C-terminal truncated HBx C40 synergizes with FXR deficiency by altering cell cycle distribution as well as disturbing glucose metabolism to promote HCC development. MDPI 2023-03-08 /pmc/articles/PMC10048952/ /pubmed/36982249 http://dx.doi.org/10.3390/ijms24065174 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wu, Xuejun Ni, Zhengzhong Song, Tiantian Lv, Wenya Chen, Yan Huang, Danmei Xie, Yangmin Huang, Weiyi Niu, Yongdong C-Terminal Truncated HBx Facilitates Oncogenesis by Modulating Cell Cycle and Glucose Metabolism in FXR-Deficient Hepatocellular Carcinoma |
title | C-Terminal Truncated HBx Facilitates Oncogenesis by Modulating Cell Cycle and Glucose Metabolism in FXR-Deficient Hepatocellular Carcinoma |
title_full | C-Terminal Truncated HBx Facilitates Oncogenesis by Modulating Cell Cycle and Glucose Metabolism in FXR-Deficient Hepatocellular Carcinoma |
title_fullStr | C-Terminal Truncated HBx Facilitates Oncogenesis by Modulating Cell Cycle and Glucose Metabolism in FXR-Deficient Hepatocellular Carcinoma |
title_full_unstemmed | C-Terminal Truncated HBx Facilitates Oncogenesis by Modulating Cell Cycle and Glucose Metabolism in FXR-Deficient Hepatocellular Carcinoma |
title_short | C-Terminal Truncated HBx Facilitates Oncogenesis by Modulating Cell Cycle and Glucose Metabolism in FXR-Deficient Hepatocellular Carcinoma |
title_sort | c-terminal truncated hbx facilitates oncogenesis by modulating cell cycle and glucose metabolism in fxr-deficient hepatocellular carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10048952/ https://www.ncbi.nlm.nih.gov/pubmed/36982249 http://dx.doi.org/10.3390/ijms24065174 |
work_keys_str_mv | AT wuxuejun cterminaltruncatedhbxfacilitatesoncogenesisbymodulatingcellcycleandglucosemetabolisminfxrdeficienthepatocellularcarcinoma AT nizhengzhong cterminaltruncatedhbxfacilitatesoncogenesisbymodulatingcellcycleandglucosemetabolisminfxrdeficienthepatocellularcarcinoma AT songtiantian cterminaltruncatedhbxfacilitatesoncogenesisbymodulatingcellcycleandglucosemetabolisminfxrdeficienthepatocellularcarcinoma AT lvwenya cterminaltruncatedhbxfacilitatesoncogenesisbymodulatingcellcycleandglucosemetabolisminfxrdeficienthepatocellularcarcinoma AT chenyan cterminaltruncatedhbxfacilitatesoncogenesisbymodulatingcellcycleandglucosemetabolisminfxrdeficienthepatocellularcarcinoma AT huangdanmei cterminaltruncatedhbxfacilitatesoncogenesisbymodulatingcellcycleandglucosemetabolisminfxrdeficienthepatocellularcarcinoma AT xieyangmin cterminaltruncatedhbxfacilitatesoncogenesisbymodulatingcellcycleandglucosemetabolisminfxrdeficienthepatocellularcarcinoma AT huangweiyi cterminaltruncatedhbxfacilitatesoncogenesisbymodulatingcellcycleandglucosemetabolisminfxrdeficienthepatocellularcarcinoma AT niuyongdong cterminaltruncatedhbxfacilitatesoncogenesisbymodulatingcellcycleandglucosemetabolisminfxrdeficienthepatocellularcarcinoma |